WASHINGTON — Executives at pharmaceutical firms have been bracing for extra info from the Trump administration this week about the way it deliberate to decrease drug costs.
That info has not but arrived, regardless of the administration’s self-imposed deadline to reveal by Wednesday the goal costs for medicine, a part of its plan to make sure People would pay not more than the lowest worth for medicine paid by peer nations.
The duty was to be carried out by well being secretary Robert F. Kennedy Jr., in response to an government order launched by President Trump final month. Requested when the “worth targets” could be issued, a White Home spokesperson instructed STAT in an e mail that they already had been.
This text is unique to STAT+ subscribers
Unlock this text — plus day by day intelligence on Capitol Hill and the life sciences trade — by subscribing to STAT+.
Have already got an account? Log in
To learn the remainder of this story subscribe to STAT+.
